Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes various treatment approaches for serious and difficult-to-treat diseases such as Alzheimer's Disease, Fragile X Syndrome and Niemann-Pick Type C.
Neurotrope
NASDAQ:NTRP ISIN:US64129T2078
News
###
981 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 2) (Last 30 Days: 6) (Since Published: 981)